Vascular inflammation and low-density lipoproteins: Is cholesterol the link? A lesson from the clinical trials
© 2017 The British Pharmacological Society. For long time, the role of LDL and inflammation in the pathogenesis of atherosclerosis have been studied independently from each other and only more recently a common platform has been suggested. Accumulation of excess cholesterol due to the presence of in...
| Main Authors: | Catapano, A., Pirillo, A., Norata, Giuseppe |
|---|---|
| Format: | Journal Article |
| Published: |
John Wiley & Sons
2017
|
| Online Access: | http://hdl.handle.net/20.500.11937/55932 |
Similar Items
Treating high density lipoprotein cholesterol (HDL-C): Quantity versus quality
by: Pirillo, A., et al.
Published: (2013)
by: Pirillo, A., et al.
Published: (2013)
Biology of proprotein convertase subtilisin kexin 9: Beyond low-density lipoprotein cholesterol lowering
by: Norata, Giuseppe, et al.
Published: (2016)
by: Norata, Giuseppe, et al.
Published: (2016)
High-density lipoprotein subfractions - What the clinicians need to know
by: Pirillo, A., et al.
Published: (2013)
by: Pirillo, A., et al.
Published: (2013)
The missing link between high-density lipoprotein cholesterol and inflammatory response in cardiovascular disease
by: Ammirati, E., et al.
Published: (2014)
by: Ammirati, E., et al.
Published: (2014)
Emerging role of high density lipoproteins as a player in the immune system
by: Norata, Giuseppe, et al.
Published: (2012)
by: Norata, Giuseppe, et al.
Published: (2012)
High density lipoproteins and atherosclerosis: Emerging aspects
by: Sala, F., et al.
Published: (2012)
by: Sala, F., et al.
Published: (2012)
The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis
by: Pirillo, A., et al.
Published: (2018)
by: Pirillo, A., et al.
Published: (2018)
High density lipoprotein cholesterol levels are an independent predictor of the progression of chronic kidney disease
by: Baragetti, A., et al.
Published: (2013)
by: Baragetti, A., et al.
Published: (2013)
Statins and periodontal inflammation: A pleiotropic effect of statins or a pleiotropic effect of LDL-cholesterol lowering?
by: Norata, Giuseppe, et al.
Published: (2014)
by: Norata, Giuseppe, et al.
Published: (2014)
Oxidizes Low Density Lipoprotein Cytoxicity and Vascular Diseases
by: Gieseg, Steven P., et al.
Published: (2009)
by: Gieseg, Steven P., et al.
Published: (2009)
Therapy and clinical trials: Aggressive statin therapy versus combined and emerging approaches
by: Catapano, A., et al.
Published: (2011)
by: Catapano, A., et al.
Published: (2011)
Targeting Cholesterol in Non-ischemic Heart Failure: A Role for LDLR Gene Therapy?
by: Catapano, A., et al.
Published: (2017)
by: Catapano, A., et al.
Published: (2017)
Does cigarette smoking exacerbate the effect of total cholesterol and high-density lipoprotein cholesterol on the risk of cardiovascular diseases?
by: Nakamura, K., et al.
Published: (2009)
by: Nakamura, K., et al.
Published: (2009)
MicroRNAs and lipoproteins: A connection beyond atherosclerosis?
by: Norata, Giuseppe, et al.
Published: (2013)
by: Norata, Giuseppe, et al.
Published: (2013)
Factors associated with nonachievement of low density
lipoprotein cholesterol target among patients with type 2 diabetes mellitus
by: Mat Yudin, Zainab
Published: (2015)
by: Mat Yudin, Zainab
Published: (2015)
Statins and skeletal muscles toxicity: From clinical trials to everyday practice
by: Norata, Giuseppe, et al.
Published: (2014)
by: Norata, Giuseppe, et al.
Published: (2014)
Arctigenin improves vascular tone and decreases inflammation in human saphenous vein
by: Daci, A., et al.
Published: (2017)
by: Daci, A., et al.
Published: (2017)
Postprandial lipemia as a cardiometabolic risk factor
by: Pirillo, A., et al.
Published: (2014)
by: Pirillo, A., et al.
Published: (2014)
Niemann-pick C1-like 1 (NPC1L1) inhibition and cardiovascular diseases
by: Pirillo, A., et al.
Published: (2016)
by: Pirillo, A., et al.
Published: (2016)
LOX-1, OxLDL, and atherosclerosis
by: Pirillo, A., et al.
Published: (2013)
by: Pirillo, A., et al.
Published: (2013)
HDLs, immunity, and atherosclerosis
by: Norata, Giuseppe, et al.
Published: (2011)
by: Norata, Giuseppe, et al.
Published: (2011)
HDL in infectious diseases and sepsis
by: Pirillo, A., et al.
Published: (2015)
by: Pirillo, A., et al.
Published: (2015)
Strategies for the use of nonstatin therapies
by: Pirillo, A., et al.
Published: (2017)
by: Pirillo, A., et al.
Published: (2017)
Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: Patient selection and perspectives
by: Catapano, A., et al.
Published: (2017)
by: Catapano, A., et al.
Published: (2017)
Heterozygous mthfr c677t polymorphism (rs1801133) is associated with higher total cholesterol/ high density lipoprotein cholesterol ratio in habitual coffee drinkers
by: Ong, Xuan
Published: (2023)
by: Ong, Xuan
Published: (2023)
Low density lipoprotein cholesterol phenotypes and their association with risk factors of cardiovascular disease among subjects attending health screening at a public university in Malaysia
by: Mazalan, Norlianah
Published: (2019)
by: Mazalan, Norlianah
Published: (2019)
Association of backfat thickness with postheparin lipoprotein lipase activity and very low density lipoprotein-subfractions in growing pigs
by: Loh, Teck Chwen, et al.
Published: (2001)
by: Loh, Teck Chwen, et al.
Published: (2001)
Apolipoprotein C-III: From Pathophysiology to Pharmacology
by: Norata, Giuseppe, et al.
Published: (2015)
by: Norata, Giuseppe, et al.
Published: (2015)
Plasma triglyceride and high density lipoprotein cholesterol are poor surrogate markers of pro-atherogenic chylomicron remnant homeostasis in subjects with the metabolic syndrome
by: Irawati, D., et al.
Published: (2016)
by: Irawati, D., et al.
Published: (2016)
Study of oxidized low density lipoprotein and augmentation index among population
by: Nazir, Mohd Hakam, et al.
Published: (2013)
by: Nazir, Mohd Hakam, et al.
Published: (2013)
HDL: To treat or not to treat?
by: Pirillo, A., et al.
Published: (2014)
by: Pirillo, A., et al.
Published: (2014)
HDL in innate and adaptive immunity
by: Catapano, A., et al.
Published: (2014)
by: Catapano, A., et al.
Published: (2014)
PCSK9 inhibition in statin-intolerant HeFH patients: What's new?
by: Casula, M., et al.
Published: (2017)
by: Casula, M., et al.
Published: (2017)
Manipulation of very low density lipoprotein metabolism to reduce fat deposition in poultry
by: Loh, Teck Chwen, et al.
by: Loh, Teck Chwen, et al.
Underlying mechanism of Oxidised High Density Lipoprotein induced Vascular Calcification and Osteoblasts Dysfunctions, and their prevention by Adiponectin / Noor Hanisa Harun
by: Harun, Noor Hanisa
Published: (2019)
by: Harun, Noor Hanisa
Published: (2019)
MicroRNA 143-145 deficiency impairs vascular function
by: Norata, Giuseppe, et al.
Published: (2012)
by: Norata, Giuseppe, et al.
Published: (2012)
Proprotein Convertase Subtilisin-Kexin type-9 (PCSK9) and triglyceride-rich lipoprotein metabolism: Facts and gaps
by: Baragetti, A., et al.
Published: (2018)
by: Baragetti, A., et al.
Published: (2018)
Efficacy of Ganoderma lucidum on plasma lipids and lipoproteins in rats fed with high cholesterol diet
by: Tong, Chow Chin, et al.
Published: (2008)
by: Tong, Chow Chin, et al.
Published: (2008)
Inflammation and Cardiovascular Cross Talk in Ischemic Vascular Diseases
by: Zauli, G., et al.
Published: (2017)
by: Zauli, G., et al.
Published: (2017)
Isolated low levels of high-density lipoprotein cholesterol are associated with an increased risk of coronary heart disease: An individual participant data meta-analysis of 23 studies in the asia-pacific region
by: Huxley, Rachel, et al.
Published: (2011)
by: Huxley, Rachel, et al.
Published: (2011)
Similar Items
-
Treating high density lipoprotein cholesterol (HDL-C): Quantity versus quality
by: Pirillo, A., et al.
Published: (2013) -
Biology of proprotein convertase subtilisin kexin 9: Beyond low-density lipoprotein cholesterol lowering
by: Norata, Giuseppe, et al.
Published: (2016) -
High-density lipoprotein subfractions - What the clinicians need to know
by: Pirillo, A., et al.
Published: (2013) -
The missing link between high-density lipoprotein cholesterol and inflammatory response in cardiovascular disease
by: Ammirati, E., et al.
Published: (2014) -
Emerging role of high density lipoproteins as a player in the immune system
by: Norata, Giuseppe, et al.
Published: (2012)